Found: 16
Select item for more details and to access through your institution.
The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients' safety.
- Published in:
- Health Informatics Journal, 2020, v. 26, n. 3, p. 1995, doi. 10.1177/1460458219895434
- By:
- Publication type:
- Article
Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase <em>(DPYD)</em> gene.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 4517, doi. 10.2147/CMAR.S174470
- By:
- Publication type:
- Article
Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility.
- Published in:
- International Journal of Hematology, 2022, v. 115, n. 1, p. 61, doi. 10.1007/s12185-021-03219-2
- By:
- Publication type:
- Article
A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.889575
- By:
- Publication type:
- Article
Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 3968, doi. 10.3390/cancers14163968
- By:
- Publication type:
- Article
Conquering the future in hospital pharmacy: Training as a pillar of success.
- Published in:
- Farmacia Hospitalaria (1130-6343), 2024, v. 48, p. TS45, doi. 10.1016/j.farma.2024.06.009
- By:
- Publication type:
- Article
Monitorización de las superficies de trabajo de medicamentos peligrosos en los Servicios de Farmacia. Documento de consenso. Guía de práctica farmacéutica de la Sociedad Española de Farmacia Hospitalaria (SEFH).
- Published in:
- Farmacia Hospitalaria (1130-6343), 2021, v. 45, n. 2, p. 96, doi. 10.7399/fh.11655
- By:
- Publication type:
- Article
Estudio observacional de la toxicidad con diferentes formulaciones de docetaxel en pacientes con cáncer de mama.
- Published in:
- Farmacia Hospitalaria (1130-6343), 2020, v. 44, n. 5, p. 192, doi. 10.7399/fh.11402
- By:
- Publication type:
- Article
Biomarcadores predictivos de respuesta a los inhibidores de los puntos de control inmunitario.
- Published in:
- Farmacia Hospitalaria (1130-6343), 2020, v. 44, n. 4, p. 141, doi. 10.7399/fh.11328
- By:
- Publication type:
- Article
A comparative study of contamination in three closed systems for the preparation of hazardous drugs through simulations with fluorescein.
- Published in:
- Farmacia Hospitalaria (1130-6343), 2018, v. 42, n. 6, p. 234, doi. 10.7399/fh.11024
- By:
- Publication type:
- Article
Aggressiveness of end-of-life cancer care: what happens in clinical practice?
- Published in:
- 2021
- By:
- Publication type:
- journal article
Erratum to: Differential toxicity biomarkers for irinotecan- and oxaliplatin- containing chemotherapy in colorectal cancer.
- Published in:
- 2013
- By:
- Publication type:
- Correction notice
Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 6, p. 1463, doi. 10.1007/s00280-013-2145-6
- By:
- Publication type:
- Article
Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2– advanced or metastatic breast cancer in Spain.
- Published in:
- ClinicoEconomics & Outcomes Research, 2018, v. 10, p. 773, doi. 10.2147/CEOR.S178934
- By:
- Publication type:
- Article
Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain.
- Published in:
- ClinicoEconomics & Outcomes Research, 2016, v. 8, p. 475, doi. 10.2147/CEOR.S114524
- By:
- Publication type:
- Article